Five things for pharma marketers to know: Tuesday, August 22, 2017

Five things for pharma marketers to know: Tuesday, August 22, 2017

Novartis launches MS study with Apple's ResearchKit; the FDA considering limiting risk info in drug ads; J&J loses baby powder lawsuit

Outcome Health hires former BMS exec Nancy Phelan

Outcome Health hires former BMS exec Nancy Phelan

She is leading commercial partnerships for the point-of-care company.

Diabetes drugs must prove their value to payers, analysts say

Diabetes drugs must prove their value to payers, analysts say

CVS Health's decision to remove Lilly's Jardiance for J&J's Invokana has analysts wondering if exclusive pricing contracts could shape the future of the GLP-1 class.

Five things for pharma marketers to know: Monday, August 21, 2017

Five things for pharma marketers to know: Monday, August 21, 2017

The FDA approves Ironwood's gout drug; GSW names new president; Samsung and Takeda to partner on biologic development

Always ad '#LikeAGirl' returns to fight girls' fear of failure

Always ad '#LikeAGirl' returns to fight girls' fear of failure

Procter & Gamble has revived the campaign with a new spot tackling the lack of confidence during puberty.

Pharma's $6 billion annual ad spend targeted by media publishers

Pharma's $6 billion annual ad spend targeted by media publishers

Condé Nast, Time Inc., and Vice Media have all recently launched health content businesses.

Sanofi adds WPP to creative roster in agency review

Sanofi adds WPP to creative roster in agency review

WPP was added to Sanofi's creative agency roster and GroupM's Mindshare is the drugmaker's new global media agency of record.

Five things for pharma marketers to know: Friday, August 18, 2017

Five things for pharma marketers to know: Friday, August 18, 2017

Lawmakers to investigate pricing of MS drugs; Mylan will pay $465 million to resolve EpiPen allegations; the FDA approves Pfizer's new cancer drug

Five things for pharma marketers to know: Thursday, August 17, 2017

Five things for pharma marketers to know: Thursday, August 17, 2017

Express Scripts to limit opioid coverage; Novo's diabetes drug lowers glucose levels in trial; startup aims to give doctors access to a patient's total costs

PhRMA criticizes the FDA's research into drug advertising and promotion

PhRMA criticizes the FDA's research into drug advertising and promotion

The lobbying group said it's unclear what the agency's goal is with this research and how it promotes public health.